-
Artificial neural network for predicting pathological stage of clinically localized prostate cancer in a Taiwanese population
Chih-Wei Tsao, Ching-Yu Liu, Tai-Lung Cha, Sheng-Tang Wu, Guang-Huan Sun, Dah-Shyong Yu, Hong-I Chen, Sun-Yran Chang, Shih-Chang
Chen, and Chien-Yeh Hsu
Journal of the Chinese Medical Association
(2014)
77 :513
-
Meta-analysis of metabolic syndrome and prostate cancer
M Gacci, G I Russo, C De Nunzio, A Sebastianelli, M Salvi, L Vignozzi, A Tubaro, G Morgia, and S Serni
Prostate Cancer and Prostatic Diseases
(2017)
20 :146
-
Androgen deprivation therapy is associated with diabetes: Evidence from meta-analysis
Huimin Wang, Xiangyu Sun, Lin Zhao, Xiuju Chen, and Jinsheng Zhao
Journal of Diabetes Investigation
(2016)
7 :629
-
Peri-prostatic adipose tissue: the metabolic microenvironment of prostate cancer
Zeyad D. Nassar, Adel T. Aref, Dushan Miladinovic, Chui Yan Mah, Ganesh V. Raj, Andrew J. Hoy, and Lisa M. Butler
BJU International
(2018)
:
-
GLP-1 receptor agonist as treatment for cancer as well as diabetes: beyond blood glucose control
Takashi Nomiyama and Toshihiko Yanase
Expert Review of Endocrinology & Metabolism
(2016)
:1
-
The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome
Consuelo Buttigliero, Federica Vana, Valentina Bertaglia, Francesca Vignani, Cristian Fiori, Giangiacomo Osella, Francesco
Porpiglia, Marcello Tucci, Giorgio Vittorio Scagliotti, and Alfredo Berruti
Endocrine
(2015)
50 :223
-
Exendin-4, a GLP-1 Receptor Agonist, Attenuates Prostate Cancer Growth
Takashi Nomiyama, Takako Kawanami, Shinichiro Irie, Yuriko Hamaguchi, Yuichi Terawaki, Kunitaka Murase, Yoko Tsutsumi, Ryoko
Nagaishi, Makito Tanabe, Hidetaka Morinaga, Tomoko Tanaka, Makio Mizoguchi, Kazuki Nabeshima, Masatoshi Tanaka, and Toshihiko
Yanase
Diabetes
(2014)
63 :3891
-
Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus
Chin-Hsiao Tseng
European Journal of Cancer
(2014)
50 :2831
-
2,3,7,8-Tetrachlorodibezo-p-dioxin exposure and prostate cancer: a meta-analysis of cohort studies
L. Leng, X. Chen, C.-P. Li, X.-Y. Luo, and N.-J. Tang
Public Health
(2014)
128 :207
-
Dissecting the Association Between Metabolic Syndrome and Prostate Cancer Risk: Analysis of a Large Clinical Cohort
Bimal Bhindi, Jennifer Locke, Shabbir M.H. Alibhai, Girish S. Kulkarni, David S. Margel, Robert J. Hamilton, Antonio Finelli,
John Trachtenberg, Alexandre R. Zlotta, Ants Toi, Karen M. Hersey, Andrew Evans, Theodorus H. van der Kwast, and Neil E. Fleshner
European Urology
(2015)
67 :64
-
Intensity-modulated radiotherapy of prostate cancer with simultaneous integrated boost after molecular imaging with 18F-choline-PET/CT
Marsha Schlenter, Vanessa Berneking, Barabara Krenkel, Felix M. Mottaghy, Thomas-Alexander Vögeli, Michael J. Eble, and Michael
Pinkawa
Strahlentherapie und Onkologie
(2018)
:
-
Androgens and prostate cancer; pathogenesis and deprivation therapy
Mathis Grossmann, Ada S. Cheung, and Jeffrey D. Zajac
Best Practice & Research Clinical Endocrinology & Metabolism
(2013)
27 :603
-
Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer
George A. M. Lins de Albuquerque, Giuliano B. Guglielmetti, João Arthur B. A. Barbosa, José Pontes Jr., Arnaldo J. C. Fazoli,
Maurício D. Cordeiro, Rafael F. Coelho, Paulo Afonso de Carvalho, Fábio P. Gallucci, Guilherme P. Padovani, Rubens Park, José
Cury, Henrique Nonemacher, Miguel Srougi, and William C. Nahas
Revista da Associação Médica Brasileira
(2017)
63 :704
-
The andrologist's contribution to a better life for ageing men: part 2
F. Comhaire and A. Mahmoud
Andrologia
(2016)
48 :99
-
Obesity, diabetes mellitus, and cancer
W. W. de Herder and C. Eng
Endocrine Related Cancer
(2012)
19 :E5
-
Cardiovascular risk and bone loss in men undergoing androgen deprivation therapy for non-metastatic prostate cancer: implementation
of standardized management guidelines
A. S. Cheung, D. Pattison, I. Bretherton, R. Hoermann, D. Lim Joon, E. Ho, T. Jenkins, E. J. Hamilton, K. Bate, I. Chan, J.
D. Zajac, and M. Grossmann
Andrology
(2013)
1 :583
-
Testosterone levels increase in association with recovery from acute fracture in men
A. S. Cheung, S. Baqar, R. Sia, R. Hoermann, S. Iuliano-Burns, T. D. T. Vu, C. Chiang, E. J. Hamilton, E. Gianatti, E. Seeman,
J. D. Zajac, and M. Grossmann
Osteoporosis International
(2014)
25 :2027
-
Low-dose-rate prostate brachytherapy: 4–8 week postimplant prostate-specific antigen a novel predictor of biochemical failure-free
survival
Cameron M. Callaghan, Lin Wang, Abhishek Alluri, Andrew Lauve, Cynthia Boyer, and William Russell
Brachytherapy
(2017)
16 :1119
-
Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer
Screening Trial
S. Koutros, T. E. Meyer, S. D. Fox, H. J. Issaq, T. D. Veenstra, W.-Y. Huang, K. Yu, D. Albanes, L. W. Chu, G. Andriole, R.
N. Hoover, A. W. Hsing, and S. I. Berndt
Carcinogenesis
(2013)
34 :2281
-
Robotic-assisted laparoscopic prostatectomy in men with metabolic syndrome
Young Suk Kwon, Michael Leapman, Russell B. McBride, Adele R. Hobbs, Shemille A. Collingwood, Kristian D. Stensland, and David
B. Samadi
Urologic Oncology: Seminars and Original Investigations
(2014)
32 :40.e9
-
Testosterone and glucose metabolism in men: current concepts and controversies
M. Grossmann
Journal of Endocrinology
(2014)
220 :R37
-
GLUT1 protects prostate cancer cells from glucose deprivation-induced oxidative stress
Pedro Gonzalez-Menendez, David Hevia, Rebeca Alonso-Arias, Alejandro Alvarez-Artime, Aida Rodriguez-Garcia, Sandrina Kinet,
Ivan Gonzalez-Pola, Naomi Taylor, Juan C. Mayo, and Rosa M. Sainz
Redox Biology
(2018)
17 :112
-
Impact of metabolic disorders on prostate cancer growth: Androgen and insulin resistance perspectives
Tashihiko Yanase, Takako Kawanami, Tomoko Tanaka, Makito Tanabe, and Takashi Nomiyama
Reproductive Medicine and Biology
(2017)
16 :252
-
Combined Treatment with Exendin-4 and Metformin Attenuates Prostate Cancer Growth
Yoko Tsutsumi, Takashi Nomiyama, Takako Kawanami, Yuriko Hamaguchi, Yuichi Terawaki, Tomoko Tanaka, Kunitaka Murase, Ryoko
Motonaga, Makito Tanabe, Toshihiko Yanase, and Zoran Culig
PLOS ONE
(2015)
10 :e0139709
-
Associations between ghrelin and ghrelin receptor polymorphisms and cancer in Caucasian populations: a meta-analysis
Noel A Pabalan, Inge Seim, Hamdi Jarjanazi, and Lisa K Chopin
BMC Genetics
(2014)
15 :
-
Current and future strategies for the nutritional management of cardiometabolic complications of androgen deprivation therapy
for prostate cancer
Lauren Turner, Karen Poole, Sara Faithfull, and Bruce A. Griffin
Nutrition Research Reviews
(2017)
30 :220
-
The dark side of glucose transporters in prostate cancer: Are they a new feature to characterize carcinomas?
Pedro Gonzalez-Menendez, David Hevia, Juan C. Mayo, and Rosa M. Sainz
International Journal of Cancer
(2018)
142 :2414
-
Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer
Events (REDUCE) study
Katharine N. Sourbeer, Lauren E. Howard, Gerald L. Andriole, Daniel M. Moreira, Ramiro Castro-Santamaria, Stephen J. Freedland,
and Adriana C. Vidal
BJU International
(2015)
115 :736
-
Exploring glyoxalase 1 expression in prostate cancer tissues: Targeting the enzyme by ethyl pyruvate defangs some malignancy-associated
properties
Martin Baunacke, Lars-Christian Horn, Susanne Trettner, Kathrin M.Y. Engel, Nasr Y.A. Hemdan, Volker Wiechmann, Jens-Uwe Stolzenburg,
Marina Bigl, and Gerd Birkenmeier
The Prostate
(2014)
74 :48
-
Metabolic syndrome and prostate cancer risk in a population-based case–control study in Montreal, Canada
Audrey Blanc-Lapierre, Andrea Spence, Pierre I. Karakiewicz, Armen Aprikian, Fred Saad, and Marie-Élise Parent
BMC Public Health
(2015)
15 :
-
Lifetime body size and prostate cancer risk in a population-based case–control study in Sweden
Elisabeth Möller, Hans-Olov Adami, Lorelei A. Mucci, Cecilia Lundholm, Rino Bellocco, Jan-Erik Johansson, Henrik Grönberg,
and Katarina Bälter
Cancer Causes & Control
(2013)
24 :2143
